%PDF-1.4
%
1 0 obj
<>
endobj
164 0 obj
<>stream
Creo Normalizer JTP
2024-03-18T18:55:41-07:00
2006-05-24T12:14:40-04:00
2024-03-18T18:55:41-07:00
uuid:a611b29b-108c-440b-a03c-113d8d55802e
uuid:0da7cab5-1dd2-11b2-0a00-6a00a809cdff
application/pdf
endstream
endobj
2 0 obj
<>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
70 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
118 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
178 0 obj
[183 0 R]
endobj
159 0 obj
<>
endobj
179 0 obj
<>stream
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
10 0 0 10 35.1648 729.8835 Tm
[(Indirect)-332.9 (Modulation)-332.9 (by)]TJ
/T1_1 1 Tf
10 0 1.554 10 146.0672 729.8835 Tm
(\002)Tj
/T1_0 1 Tf
10 0 0 10 152.1769 729.8835 Tm
[(7)-332.9 (N)0.1 (icotinic)-332.9 (Acetylcholine)-332.9 (Receptors)-332.9 (of)-332.9 (Noradrenaline)-332.9 (Release)-332.9 (in)-332.9 (Rat)]TJ
-9.7012 -1.2 Td
[(Hippocampal)-332.9 (Slices:)-332.9 (Interaction)-332.9 (with)-332.9 (Glutamate)-332.9 (and)-332.9 (GABA)-332.9 (Systems)-332.9 (and)-332.9 (Effect)-332.9 (of)-332.9 (Nicotine)]TJ
0 -1.2 TD
(Withdrawal)Tj
/T1_2 1 Tf
T*
[(Jacques)-332.9 (Barik)-332.9 (and)-332.9 (Susan)-332.9 (Wonnacott)]TJ
/T1_0 1 Tf
47.9329 0 Td
(618)Tj
-49.9329 -2.2 Td
[(Acquired)-332.9 (Cadmium)-332.9 (Resistance)-332.9 (in)-332.9 (Metallothionein-I/II\()]TJ
/T1_3 1 Tf
25.4773 0 Td
(\003)Tj
/T1_0 1 Tf
[0.1 (/)]TJ
/T1_3 1 Tf
(\003)Tj
/T1_0 1 Tf
[0.1 (\))-332.9 (Knockout)-332.9 (Cells:)-332.9 (Role)-332.9 (of)-332.9 (the)-332.9 (T-Type)-332.9 (Calcium)]TJ
-23.4774 -1.2 Td
[(Channel)-332.9 (Cacn)]TJ
/T1_1 1 Tf
10 0 1.554 10 121.0805 659.8835 Tm
(\002)Tj
/T1_0 1 Tf
7.5 0 0 6.5 127.1901 657.6335 Tm
(1G)Tj
10 0 0 10 140.5247 659.8835 Tm
[(in)-332.9 (Cadmium)-332.9 (Uptake)]TJ
/T1_2 1 Tf
-8.536 -1.2 Td
[(Elaine)-332.9 (M.)-332.9 (Leslie,)-332.9 (Jie)-332.9 (Liu,)-332.9 (Curtis)-332.9 (D.)-332.9 (Klaassen,)-332.9 (and)-332.9 (Michael)-332.9 (P.)-332.9 (Waalkes)]TJ
/T1_0 1 Tf
47.9329 0 Td
(629)Tj
/T1_4 1 Tf
8 0 0 8 22.1648 625.8835 Tm
(\001)Tj
/T1_0 1 Tf
6 0 0 6 24.3266 625.8835 Tm
(S)Tj
10 0 0 10 35.1665 625.8835 Tm
[(Pharmacological)-332.9 (Properties)-332.9 (of)-332.9 (GABA)]TJ
7.5 0 0 6.5 207.3652 623.6335 Tm
(A)Tj
10 0 0 10 216.1097 625.8835 Tm
[(Receptors)-332.9 (Containing)]TJ
/T1_1 1 Tf
10 0 1.554 10 319.7929 625.8835 Tm
(\001)Tj
/T1_0 1 Tf
10 0 0 10 325.3526 625.8835 Tm
[(1)-332.9 (Subunits)]TJ
/T1_2 1 Tf
-27.0188 -1.2 Td
[(S.)-332.9 (Khom,)-332.9 (I.)-332.9 (Baburin,)-332.9 (E.)-332.9 (N.)-332.9 (Timin,)-332.9 (A.)-332.9 (Hohaus,)-332.9 (W.)-332.9 (Sieghart,)-332.9 (and)-332.9 (S.)-332.9 (Hering)]TJ
/T1_0 1 Tf
47.9329 0 Td
(640)Tj
-49.9329 -2.2 Td
[(Deficiency)-332.9 (of)-332.9 (Glutathione)-332.9 (Transferase)-332.9 (Zeta)-332.9 (Causes)-332.9 (Oxidative)-332.9 (Stress)-332.9 (and)-332.9 (Activation)-332.9 (of)-332.9 (Antioxidant)]TJ
2 -1.2 Td
[(Response)-332.9 (Pathways)]TJ
/T1_2 1 Tf
T*
[(Anneke)-332.9 (C.)-332.9 (Blackburn,)-332.9 (Klaus)-332.9 (I.)-332.9 (Matthaei,)-332.9 (Cindy)-332.9 (Lim,)-332.9 (M)0.1 (atthew)-332.9 (C.)-332.9 (Taylor,)-332.9 (Jean)-332.9 (Y.)-332.9 (Cappello,)]TJ
T*
[(John)-332.9 (D.)-332.9 (Hayes,)-332.9 (M.)-332.9 (W.)-332.9 (Anders,)-332.9 (and)-332.9 (Philip)-332.9 (G.)-332.9 (Board)]TJ
/T1_0 1 Tf
47.9329 0 Td
(650)Tj
-49.9329 -2.2 Td
[(Mechanism)-332.9 (of)-332.9 (Action)-332.9 (of)-332.9 (a)-332.9 (Novel)-332.9 (Human)]TJ
/T1_2 1 Tf
19.0327 0 Td
(ether-a-go-go)Tj
/T1_0 1 Tf
[0.4 (-Related)-332.9 (Gene)-332.9 (Channel)-332.9 (Activator)]TJ
/T1_2 1 Tf
-17.0327 -1.2 Td
[(Oscar)-332.9 (Casis,)-332.9 (S\370ren-Peter)-332.9 (Olesen,)-332.9 (and)-332.9 (Michael)-332.9 (C.)-332.9 (Sanguinetti)]TJ
/T1_0 1 Tf
47.9329 0 Td
(658)Tj
-49.9329 -2.2 Td
[(Biological)-332.9 (Consequences)-332.9 (of)-332.9 (Trinuclear)-332.9 (Platinum)-332.9 (Complexes:)-332.9 (Comparison)-332.9 (of)-332.9 ([{)]TJ
/T1_2 1 Tf
36.1056 0 Td
(trans)Tj
/T1_0 1 Tf
[0.1 (-PtCl\(NH)]TJ
7.5 0 0 6.5 464.5366 497.6335 Tm
(3)Tj
10 0 0 10 468.7066 499.8835 Tm
(\))Tj
7.5 0 0 6.5 472.0364 497.6335 Tm
(2)Tj
10 0 0 10 476.2064 499.8835 Tm
(})Tj
7.5 0 0 6.5 479.5362 497.6335 Tm
(2)Tj
/T1_1 1 Tf
10 0 1.554 10 483.7062 499.8835 Tm
(\006)Tj
/T1_0 1 Tf
10 0 0 10 490.3758 499.8835 Tm
(-)Tj
-43.5211 -1.2 Td
(\()Tj
/T1_2 1 Tf
(trans)Tj
/T1_0 1 Tf
[0.1 (-Pt\(NH)]TJ
7.5 0 0 6.5 116.441 485.6335 Tm
(3)Tj
10 0 0 10 120.611 487.8835 Tm
(\))Tj
7.5 0 0 6.5 123.9408 485.6335 Tm
(2)Tj
10 0 0 10 128.1108 487.8835 Tm
(\(H)Tj
7.5 0 0 6.5 139.7701 485.6335 Tm
(2)Tj
10 0 0 10 143.9401 487.8835 Tm
(N\(CH)Tj
7.5 0 0 6.5 170.9685 485.6335 Tm
(2)Tj
10 0 0 10 175.1385 487.8835 Tm
(\))Tj
7.5 0 0 6.5 178.4683 485.6335 Tm
(6)Tj
-0.00011 Tc 10 0 0 10 182.6383 487.8835 Tm
(NH)Tj
0 Tc 7.5 0 0 6.5 199.1172 485.6335 Tm
(2)Tj
10 0 0 10 203.2873 487.8835 Tm
(\))Tj
7.5 0 0 6.5 206.6171 485.6335 Tm
(2)Tj
10 0 0 10 210.787 487.8835 Tm
(\)])Tj
7.5 0 0 6.5 217.4467 492.1335 Tm
(4)Tj
/T1_3 1 Tf
(\002)Tj
/T1_0 1 Tf
10 0 0 10 231.1937 487.8835 Tm
[(\(BBR)-332.9 (3464\))-332.9 (with)-332.9 (Its)-332.9 (Noncovalent)-332.9 (Congeners)]TJ
/T1_2 1 Tf
-17.6029 -1.2 Td
[(Amanda)-332.9 (L.)-332.9 (Harris,)-332.9 (John)-332.9 (J.)-332.9 (Ryan,)-332.9 (and)-332.9 (Nicholas)-332.9 (Farrell)]TJ
/T1_0 1 Tf
47.9329 0 Td
(666)Tj
/T1_4 1 Tf
9 0 0 9 35.1648 85.3835 Tm
(\001)Tj
/T1_0 1 Tf
7 0 0 7 37.5962 85.3835 Tm
(S)Tj
10 0 0 10 47.0063 85.3835 Tm
[(Supplemental)-332.9 (material)-332.9 (is)-332.9 (available)-332.9 (online)-332.9 (at)-332.9 (http://molpharm.aspetjournals.org.)]TJ
/T1_2 1 Tf
8 0 0 8 50.1648 50.3835 Tm
[(About)-291.5 (the)-291.5 (cover:)]TJ
/T1_0 1 Tf
7.842 0 Td
[(AC5)-291.5 (probe)-291.5 (orientation)-291.5 (into)-291.5 (an)-291.5 (ACh)-291.5 (binding)-291.5 (site)-291.5 (of)-291.5 (a)-291.5 (presumed)-291.5 (resting)-291.5 (state-like)-291.5 (AChBP)-291.5 (structure.)-291.5 (See)-291.5 (the)-291.5 (article)]TJ
-7.842 -1.25 Td
[(by)-332.7 (Mourot)-332.7 (et)-332.7 (al.)-332.7 (on)-332.7 (page)-332.7 (452)-332.7 (of)-332.7 (this)-332.7 (issue.)]TJ
ET
1 0 0 1 -9 -9 cm
/CS0 CS 1 SCN
48.5 w
/GS1 gs
44.165 58.134 m
47.165 58.134 l
S
3 w
47.165 80.884 m
558.165 80.884 l
S
48.5 w
555.165 58.134 m
558.165 58.134 l
S
3 w
44.165 35.383 m
555.165 35.383 l
S
1 0 0 1 9 9 cm
BT
0 g
/GS2 gs
/T1_5 1 Tf
0 -9 9 0 568 377.75706 Tm
( at ASPET Journals on March 18, 2024)Tj
/GS2 gs
-11.22099 0 Td
(molpharm.aspetjournals.org)Tj
/GS2 gs
-7.55399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
144 0 obj
<>
endobj
121 0 obj
<>
endobj
124 0 obj
<>
endobj
128 0 obj
<>
endobj
131 0 obj
<>
endobj
135 0 obj
<>
endobj
172 0 obj
<>
endobj
136 0 obj
<>
endobj
138 0 obj
<>
endobj
137 0 obj
<>stream
HTPj0+tLqho!Prfwd
l琿MwAid:r'{ceጣ#PXgmh&@&qu-WΑW(^lP)NHJh8پ'ewjn-AdM#B]
HOqEnV/iwg*r`mw%K
0 %h^
endstream
endobj
139 0 obj
<>stream
Hbd`ad`ddTr,K-*NK-/.,p
!C,X_?'~'=PpF!fFFvd##scʢdMCKǔTbϼĒ=ǜ bԢ2(N00030f0012h_wk2̿~>/uwf]` \c
endstream
endobj
132 0 obj
<>
endobj
133 0 obj
<>
endobj
134 0 obj
<>stream
Hbd`ab`ddTrt,K-*Nu/JM.,M,)R!C